Contrasting contributions of TNF from distinct cellular sources in arthritis

OBJECTIVES: Neutralisation of tumour necrosis factor (TNF) is widely used as a therapy for rheumatoid arthritis (RA). However, this therapy is only effective in less than a half of patients and is associated with several side effects. We hypothesised that TNF may possess non-redundant protective and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Rheum Dis
Egile Nagusiak: Kruglov, Andrey, Drutskaya, Marina, Schlienz, Dirk, Gorshkova, Ekaterina, Kurz, Katharina, Morawietz, Lars, Nedospasov, Sergei
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2020
Gaiak:
Rheumatoid Arthritis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7569389/
https://ncbi.nlm.nih.gov/pubmed/32796044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2019-216068
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak